CJMB - Kewajiban jangka dawa marang modal callanjmb.com

Callan JMB Inc (CJMB) develops specialized medical equipment, with profitability gradually increasing as the clinical application of its products expands. This daily price chart reflects the asset's dynamics, where the indicator stands at 2.67. The business relies on robust agreements with clinics, which rarely switch suppliers due to the costs associated with retraining physicians. The constant supply of operating room consumables ensures a steady stream of profit for the company.

Callan JMB (CJMB): Utang jangka dawa marang modal saka 06.02.2025 nganti 28.10.2026

This ratio determines the company's dependence on long-term credit obligations relative to its equity. By analyzing long-term debt-to-equity, an investor assesses financial stability and the cost of borrowing. The metric reflects the balance between external financing and internal resources. For Callan JMB (CJMB), this serves as an indicator for scaling niche medical solutions. An increase in this figure may signal investments in equipment for surgical centers.

Analisis pesaing

Rasio utang jangka dawa marang ekuitas Intuitive Surgical, Inc.|Danaher Corp - Utang jangka dawa marang modal|Kewajiban jangka dawa marang modal Becton Dickinson & Company (BDX)|STE - Utang jangka dawa marang modal|Rasio utang jangka dawa marang modal westpharma.com WST|Utang jangka dawa marang modal BAX (Baxter)|MASI - Rasio tanggungan utang jangka dawa marang modal|STVN (Stevanato) - Utang jangka dawa marang modal|Teleflex Corp (TFX) - Rasio utang jangka dawa marang ekuitas|MMSI (Merit Medical Systems) - Utang jangka dawa marang modal|Utang jangka dawa marang modal NVST|Utang jangka dawa marang ekuitas ICU Medical (ICUI)|Utang jangka dawa marang ekuitas Dentsply Sirona Inc XRAY|Rasio utang jangka dawa marang ekuitas LeMaitre|Koefisien utang jangka dawa marang modal AtriCure Medical ATRC|Utang jangka dawa marang modal STAA (STAAR Surgical Company)|NAGE: Rasio tanggungan utang jangka dawa marang modal|Utang jangka dawa marang ekuitas ZimVie|ANGO (AngioDynamics Inc) - Rasio utang jangka dawa marang modal|CERS: Utang jangka dawa marang ekuitas|Rasio tanggungan utang jangka dawa marang modal Teknova Inc (TKNO)|Rasio utang jangka dawa marang ekuitas Monogram Technologies|Rasio silihan jangka dawa marang modal STSS (sharpstechnology.com)|Utang jangka dawa marang ekuitas InfuSystem Holdings, Inc.|UTMD - Koefisien utang jangka dawa marang modal|KORU Medical Systems Inc. - Rasio utang jangka dawa marang ekuitas|NYXH: Utang jangka dawa marang modal|MBOT (Microbot Medical Inc.) - Utang jangka dawa marang ekuitas|pro-dex.com (PDEX) - Rasio utang jangka dawa marang ekuitas|Utang jangka dawa marang modal ZTEK (Zentek)|Kewajiban jangka dawa marang modal ELUT|Utang jangka dawa marang ekuitas Milestone Scientific Corp MLSS|Rasio utang jangka dawa marang modal NEXGEL Inc NXGL|Rasio utang jangka dawa marang ekuitas Retractable Technologies, Inc. (RVP)|Harvard Bioscience Inc. - Rasio silihan jangka dawa marang modal|Utang jangka dawa marang ekuitas FEMY (Femasys)|MHUA - Rasio tanggungan utang jangka dawa marang modal|POAI (predictive-oncology.com) - Utang jangka dawa marang modal|Atrion Corporation Inc. (ATRI) - Rasio utang jangka dawa marang ekuitas|NURO (NeuroMetrix, Inc.) - Utang jangka dawa marang modal